Therefore, we presume that the activation of Nrf2 in myenteric neurons may inhibit the NFκB pathway in the ganglia of the duodenum and may contribute to neuronal survival through the enhancement of antioxidant mechanisms in this particular intestinal segment in type 1 diabetes [40,54]. Here, NFE2L2 is linked to type 1 diabetes mellitus.